Yeast Genetics and Molecular Biology 1998
College Park, Maryland
August 1998


Name: Keil, Ralph L.
Mailing Address: Biochem and Mol Biol H171, Hershey Medical Center, 500 University Dr., Hershey, PA 17033, USA
Email Address: rlk9@psu.edu
Phone and Fax numbers: 1-717-531-8595, 1-717-531-7072

071

Ubiquitin metabolism is involved in cellular sensitivity to volatile anesthetics.


Darren Wolfe, Ralph L. Keil
Biochem and Mol Biol H171, Hershey Medical Center, 500 University Dr., Hershey, PA 17033, USA

In addition to inducing the physiologic state called anesthesia, volatile anesthetics affect all cells tested. The cellular basis of any effects of these agents has not been defined. In yeast, cell division is inhibited. Genetic analysis of yeast mutants that grow in a normally inhibitory atmosphere of volatile anesthetic identified seven different genes, ZZZ1-ZZZ7 , that confer resistance when mutated. Analysis of double mutant strains shows that mutations in all seven genes interact epistatically, suggesting that the gene products may be components of a single pathway. The ZZZ1 , ZZZ2 , and ZZZ4 genes have been cloned and analyzed. ZZZ2 is UBC4 , which encodes an enzyme required for conjugation of ubiquitin to certain substrates. The product of ZZZ1 , also called BUL1 , binds directly to ubiquitin ligase. ZZZ4 has been identified as DOA1/UFD3 . Doa1/ufd3/zzz4 mutants have altered protein degradation and low intracellular levels of ubiquitin. Deletion of ZZZ1 , ZZZ2 , or ZZZ4 renders cells anesthetic resistant, indicating that absence of the gene product alters cellular sensitivity. Thus ubiquitination, a posttranslational modification that can alter turnover or function of a protein, affects cellular response to anesthetics. Our findings are consistent with models in which anesthetic exposure directly stimulates the ubiquitination path or with models in which ubiquitination indirectly affects cellular response by regulating the activity or level of an anesthetic target.


Return to YGM 1998 Abstract Index